Cardiology
Research on bremelanotide (PT-141), a melanocortin receptor agonist peptide studied for hypoactive sexual desire disorder.
No claims extracted for this topic
Bremelanotide (also known as Bremelanotide, PT-141, Vyleesi). Research on bremelanotide (PT-141), a melanocortin receptor agonist peptide studied for hypoactive sexual desire disorder.
As of 2026-06-26, the scientific consensus on Bremelanotide is unknown. No claims extracted for this topic
This evidence brief synthesizes Synapse's enriched cardiology corpus; cite as synapsesocial.com/topics/6a20b94f2eacf7592fbe2c19.
Deterministic synthesis from Synapse's enriched corpus — 49 words. No AI-generated novel content; every figure is sourced from the underlying paper, guideline, or trial record linked on this page.
Explore every Bremelanotide paper on Synapse with AI-enriched clinical evidence, PICO analysis, and methodology classification.
Search Bremelanotide papersPowered by Synapse — AI-enriched analysis of 600,000+ peer-reviewed papers